VaramirStart free · no cardSign in
NGNE as of Nov 1 · 10:25 ET
NGNENasdaqPharmaceutical Preparations

Neurogene Inc. · Brief

Next report

11 days

Nov 12 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±19.4%
avg realized
±6.2%
Nov 18 '24±18.6%▼−13.07%×0.70
Mar 24 '25±21.4%▲+1.72%×0.08
May 9 '25±24.9%▼−1.80%×0.07
Aug 11 '25±20.2%▼−5.55%×0.28
Q3 FY25±20.1%▼−14.04%×0.70
Q1 FY26±21.7%▲+7.95%×0.37
May 12 '26±15.1%▲+3.42%×0.23
Q2 FY26±13.1%▼−2.05%×0.16
quarterimplied−25%0+25%realized×
Q2 FY26±13.1%▼−2.05%×0.16
May '26±15.1%▲+3.42%×0.23
Q1 FY26±21.7%▲+7.95%×0.37
Q3 FY25±20.1%▼−14.04%×0.70
Aug '25±20.2%▼−5.55%×0.28
May '25±24.9%▼−1.80%×0.07
2 older reports
Mar '25±21.4%▲+1.72%×0.08
Nov '24±18.6%▼−13.07%×0.70
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 12 report · est.

Bull2

112managers reporting a position in the latest quarterly filings13F · Jun 30 '26
+1.43%change in shares held by the largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2 of 4

8 of 8recent reports where the move came in under the options implied rangeEarnings history
0.01%of iShares Russell 2000 ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

NGNE report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 29impliedImplied move: ±16.4% into Nov 12 earnings (Oct 29 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.